ArticleHistology and histopathology2023

Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression.

Xia Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.